About 3 results found for searched term "NX-13" (0.395 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3730 | CNX-1351 | PI3K |
| Cnx-1351 is an effective selective PI3Kα inhibitor with an IC50 of 6.8 nM. | ||
| M45116 | NX-13 | NLR |
| Amelenodor | ||
| NX-13 is a novel oral small molecule NLRX1 agonist, which can increase oxidative phosphorylation in immune cells, decrease the differentiation of effector CD4+ T cells, and reduce the production of inflammatory cytokines in the gastrointestinal tract through activation of the NLRX1 pathway, and can be used in studies related to ulcerative colitis (UC). | ||
| M2003 | PF-04929113 | HSP |
| SNX-5422 | ||
| PF-04929113 (SNX-5422) is a potent and selective Hsp90 inhibitor with Kd of 41 nM. SNX-5422 (PF-04929113) also induces Her-2 degradation, with an IC50 of 37 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
